Also, the increased incidence of breast cancer associated with the melatonin pathway genes is thought to be due to melatonin binding to and activation of MT1 and MT2, the melatonin receptors encoded by the MTNR1A and MTNR1B genes, triggering anti-oncostatic actions in human breast cancer cells10. Here, MTNR1A is linked to breast carcinoma.